Delivery Order SPE2DB20D1047-SPE2DB24FF63F

Award Date 4/18/24
Potential Completion Date 4/19/24
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,930.74 firm-fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 3, 2024 and was not designated under any set-aside program. Amerisourcebergen holds a $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The single-award indefinite delivery contract (IDC) is with the Defense Logistics Agency (DLA) Troop Support Medical and is valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $7,828.00 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 5, 2024 with a completion date of June 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs) with federal agencies. The...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides delivery orders for the supply of AIMOVIG 140 MG/ML autoinjectors to the Defense Logistics Agency (DLA). The $7,244.57 firm fixed-price contract has a completion date of February 27, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML autoinjectors to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The $10,534.00 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, under an existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Aimovig 140 mg/ml autoinjector medication to the Defense Logistics Agency (DLA). The $2,749.26 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of May 6, 2024 and is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,314.66 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of November 15, 2022 and was awarded on November 14, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of AIMOVIG 70 mg/mL autoinjector to the Defense Logistics Agency (DLA). The contract, valued at $13,121.30, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 13, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded on July 12, 2024 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, and has a ceiling value of $1,357.86. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 15, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the pharmaceutical product Aimovig 140 mg/mL Autoinjector, awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 and runs through December 31, 2025, serving as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB24FF63F
    Delivery Order

This federal contract award is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,355.73 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract award does not have a set-aside designation.

Generated 7/18/24, 9:04 AM